Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two executive appointments at Amylin

This article was originally published in Scrip

Executive Summary

Amylin Pharmaceuticals (US) has named Dr Christian Weyer senior vice-president of R&D. During his 10-year tenure at Amylin, Dr Weyer has served in leadership roles in research, clinical and corporate development, most recently as vice-president of medical development. Dr Orville Kolterman, who was formerly senior vice-president of R&D, takes on the new role of chief medical officer.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC009029

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel